Barrington Strategic Wealth Management Group’s Gilead Sciences GILD Stock Holding History

Barrington Strategic Wealth Management Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$655K	Sell	8,084 -80	-1%	-$6.12K	0.33%	77
2017 Q2	$578K	Buy	8,164 +216	+3%	+$14.4K	0.29%	82
2017 Q1	$540K	Buy	7,948 +15	+0.2%	+$1.05K	0.28%	84
2016 Q4	$568K	Buy	7,933 +67	+0.9%	+$4.98K	0.3%	82
2016 Q3	$622K	Sell	7,866 -35	-0.4%	-$2.84K	0.35%	76
2016 Q2	$659K	Buy	7,901 +5,022	+174%	+$446K	0.38%	69
2016 Q1	$264K	Sell	2,879 -83	-3%	-$7.49K	0.15%	90
2015 Q4	$300K	Buy	+2,962	New	+$308K	0.18%	92

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barrington Strategic Wealth Management Group's GILD Position: Q3 2017 in Review

Barrington Strategic Wealth Management Group reduced its Gilead Sciences (GILD) stake by 0.98% in Q3 2017, selling an estimated $6.12K and leaving 8,084 shares worth $655K. The position accounts for 0.33% of the portfolio, ranked #77.

Barrington Strategic Wealth Management Group first reported a position in GILD in Q4 2015 and has held it in 8 quarters since. The position peaked at $659K in Q2 2016. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

Barrington Strategic Wealth Management Group held 8,084 shares of Gilead Sciences worth $655K as of Q3 2017.
Barrington Strategic Wealth Management Group sold 80 Gilead Sciences shares in Q3 2017, an estimated $6.12K.
Gilead Sciences made up 0.33% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #77 holding.
Barrington Strategic Wealth Management Group first reported a position in Gilead Sciences in Q4 2015 and has held it in 8 quarters since.
Barrington Strategic Wealth Management Group's Gilead Sciences position peaked at $659K in Q2 2016.
1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.